Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 152
Selected: 0
NCT IDTitle
NCT05430399Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer
NCT07209787SIS-Reinforced vs. Conventional Anastomosis for Mid-to-Low Rectal Cancer: A Multicenter RCT on Anastomotic Leak
NCT05244499Evidence-based Leadership in Nurse Leaders-CH
NCT02958111Single-agent Capecitabine as Adjuvant Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT04337632Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
NCT06022770Clinical Study on Nutrition Intervention in Patients With Esophageal and Gastric Cancer Treated With Chemotherapy
NCT05882630Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
NCT04239443Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine Cancer
NCT05980208A Real-world Study of Inetetamab for First-line Treatment of MBC
NCT06328439A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors
NCT02527057Diffusion-weighted Magnetic Resonance Imaging (DW-MRI )for Early Response Assessment in Patients With Esophageal Cancer
NCT05001971Anlotinib Plus Penpulimab as Second-line Treatment for Patients With Small Cell Lung Cancer After Failure of Platinum-based Chemotherapy
NCT07314216Firmonertinib Combined With Definitive Radiotherapy in Stage III Unresectable EGFR Uncommon Mutant Pulmonary Adenocarcinoma
NCT03994744Assessing Safety and Efficacy of Sintilimab and Metformin Combination Therapy in SCLC
NCT05211232Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma
NCT05113017The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)
NCT03146455Thromboelastography Normal Reference Values in China Hunan Province
NCT02395705Neoadjuvant Chemotherapy Versus Surgery Alone for Esophageal Squamous Cell Carcinoma
NCT06462105Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
NCT07303283Becotatug Vedotin as Adjuvant Therapy For High-risk Nasopharyngeal Carcinoma
NCT03066310Urine-DNA Biomarkers in Detecting Bladder Cancer
NCT05461690Phase II Study of Niraparib in Metastatic TNBC Patients With Homologous Recombination Deficiency
NCT05367739Real World Study on the Efficacy and Safety of Anti-HER2 Therapy
NCT04922567Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
NCT04459078Clinical Study of Camrelizumab Combined With APatinib and Albumin Paclitacxel in Patients With Advanced Lung Adenocarcinoma
NCT05151549A Study of Carilizumab Combined With Concurrent Chemoradiotherapy
NCT05812534Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases
NCT07584954Phase I, Open-labeled, Dose-escalation, Dose-expansion Study Evaluating the Safety, Tolerance, Pharmacokinetics, and Activity of IUAb190708 in Patients With Advanced or Recurrent Solid Tumors
NCT06458673A Prospective, Non-interventional Cohort Study of Subsolid Pulmonary Nodules
NCT02971345Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
NCT04103853Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
NCT05460481Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors
NCT02717923A Single Arm, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Maintenance Treatment With Capecitabine Plus Cetuximab in Metastatic Colorectal Cancer
NCT06737913HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
NCT07687225Surgery vs. No Surgery for Primary Tumor in De Novo Stage IV Breast Cancer With Solitary Bone Metastases
NCT07098026Shenqi Fuwei Mixture Combined With Chemotherapy Neoadjuvant Therapy for Locally Advanced Gastric Cancer
NCT02355249Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT03286920Effect of Postoperative Family Nutrition Mode on Weight/BMI of Patients With Esophageal Cancer
NCT05356351An Open-label, Single-arm, Multicenter Phase II Clinical Study: Evaluating RC48-ADC Combined With Triplizumab in the Neoadjuvant Treatment of Her2-positive Muscle-invasive Bladder Cancer
NCT07459296Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
NCT07627620Camrelizumab Combined With Famitinib Malate and Chemotherapy for Treatment of Recurrent/ Metastatic Cervical Cancer
NCT06190652Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.
NCT05869097Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
NCT04826406A Study of Camrelizumab Combined Apatinib in Hepatocellular Carcinoma Previously Treated With Immune Checkpoint Inhibitors (ICIs).
NCT06031376Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
NCT04193319Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects
NCT07402525Postoperative Radiotherapy for Early-stage Oral Tongue Squamous Cell Carcinoma Patients With Risk Factors: a Prospective, Multicenter, Randomized Controlled, Open-labelled Trial
NCT05079074Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05955391TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)
NCT06830083Hypofractionated Radiation Fractionation in Breast Cancer Patients With Implant-Based Reconstruction